Vandy scientists allowed to proceed with Alzheimer’s drug clinical trial

Written By Alex tapper

WKRN Nashville

Alex tapper

Just here to help out.

Previous

Academic drug discovery centers adapt to shifts in funding sources
Next

Researchers eye potential schizophrenia ‘switch’